Compare Inovio Pharmaceuticals Inc (INO) vs Williams Companies Inc (WMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Williams Companies Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Williams Companies Inc trades at $73.43 (market cap $90.70B). The key difference: Williams Companies Inc is far larger — about 1016× Inovio Pharmaceuticals Inc's market cap, and Williams Companies Inc pays a 2.83% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | WMB | |
|---|---|---|
Market Cap | $89.27M | $90.70B |
Sector | Health | Energy |
52-Week High | $2.87 | $79.40 |
52-Week Low | $1.05 | $56.51 |
Enterprise Value | $60.28M | $120.08B |
Dividend Yield | — | 2.83% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Williams Companies Inc
Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →
